Isabel Britsch
6PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 29, 2025
CD19-ReTARG<sup>TPR</sup>: A Novel Fusion Protein for Physiological Engagement of Anti-CMV Cytotoxic T Cells Against CD19-Expressing Malignancies.Anne Paulien van Wijngaarden, Isabel Britsch, Matthias Peipp
|Sep 21, 2023
Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR.Emily Maria Ploeg, Douwe Freerk Samplonius, Xiao Xiong
|Aug 12, 2023
Applications of Anti-Cytomegalovirus T Cells for Cancer (Immuno)Therapy.Isabel Britsch, Anne Paulien van Wijngaarden, Wijnand Helfrich
|May 14, 2023
Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cells.Isabel Britsch, Anne P van Wijngaarden, Xiurong Ke
|Dec 03, 2021
Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axis.Mark A J M Hendriks, Isabel Britsch, Xiurong Ke
|Dec 10, 2020
Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα "don't eat me" immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation.Mark A J M Hendriks, Emily M Ploeg, Iris Koopmans
Pageof 1
Frequent Collaborators
6 joint publications
Wijnand Helfrich
5 joint publications
Douwe Freerk Samplonius
5 joint publications
Anne Paulien van Wijngaarden
4 joint publications
Mark Alexander Johannes Martinus Hendriks
4 joint publications
Emily Maria Ploeg
2 joint publications
Xiurong Ke
2 joint publications
Xiurong Ke
1 joint publications
Iris Koopmans
1 joint publications
Hao Zhang
